// App-Quantinova.ai

P5-06-08 : Predicting distant recurrence of ER+ HER2- breast cancer after 5 years of endocrine therapy: The CTS5-tool validation in real life

Researchers

Presenter

  • Josephine Van Cauwenberge

Principal Investigators

  • Ivana Sestak

  • Kevin Punie

  • Hans Wildiers

  • Giuseppe Floris

  • Ignace Vergote

  • Patrick Berteloot

  • Toon Van Gorp

  • Ann Smeets

  • Els Van Nieuwenhuysen

  • Sileny Han

  • Ines Nevelsteen

  • Caroline Weltens

  • Hilde Janssen

  • Patrick Neven

Medical Centers

  • KU Leuven, Leuven, Belgium

  • Queen Mary University of London, London, United Kingdom

  • KU Leuven, Leuven, Belgium

Locations

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved